Woodline Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $11 Billion distributed in 586 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Meta Platforms, Inc. with a value of $242M, Gilead Sciences, Inc. with a value of $162M, Abb Vie Inc. with a value of $160M, Revolution Medicines, Inc. with a value of $156M, and Vaxcyte, Inc. with a value of $126M.

Examining the 13F form we can see an increase of $1.05B in the current position value, from $9.97B to 11B.

Woodline Partners LP is based out at San Francisco, CA

Below you can find more details about Woodline Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $11 Billion
Healthcare: $4.6 Billion
Technology: $2.09 Billion
Industrials: $883 Million
Financial Services: $722 Million
Energy: $697 Million
Consumer Cyclical: $646 Million
Communication Services: $630 Million
Consumer Defensive: $383 Million
Other: $371 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 586
  • Current Value $11 Billion
  • Prior Value $9.97 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 203 stocks
  • Additional Purchases 219 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 152 stocks
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.